Get the Stockscreener App
12.71
2.08%
-0.27
Alpha Tau Medical Ltd stock is traded at $12.71, with a volume of 640.37K.
It is down -2.08% in the last 24 hours and up +37.55% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
See More
Previous Close:
$12.98
Open:
$12.89
24h Volume:
640.37K
Relative Volume:
0.77
Market Cap:
$1.15B
Revenue:
-
Net Income/Loss:
$-56.88M
P/E Ratio:
-19.25
EPS:
-0.6604
Net Cash Flow:
$-39.43M
1W Performance:
-3.93%
1M Performance:
+37.55%
6M Performance:
+83.41%
1Y Performance:
+303.49%
1-Day Range:
$12.01
$13.40
1-Week Range:
$12.01
$14.11
52-Week Range:
$2.87
$14.11
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
12.71 | 1.15B | 0 | -56.88M | -39.43M | -0.6604 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
View All
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Top Executive Makes Bold Move in Alpha Tau Medical’s Latest Insider Trade - TipRanks
Alpha Tau Medical stock tracks a thin session. Investors watch its listing and filings. - ad-hoc-news.de
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS) - Seeking Alpha
Alpha Tau Medical (DRTS) CFO trades 2,270 shares in exercise and sale - Stock Titan
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd. – BOATS:DRTS - TradingView
Major Insider Move at Alpha Tau Medical Shakes Up Investor Buzz - TipRanks
Insider Sell: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
Alpha Tau Medical (DRTS) Is Up 17.9% After First International Alpha DaRT Glioblastoma Procedure – Has The Bull Case Changed? - simplywall.st
Form 144 Alpha Tau Medical Ltd. For: 6 July By Investing.com - Investing.com Nigeria
Alpha Tau Medical (DRTS) notice: 20,000 shares from option exercise to be sold - Stock Titan
Alpha Tau Medical (DRTS) CFO exercises 17,873 options and sells 17,873 shares - Stock Titan
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Alpha Tau Medical (NASDAQ: DRTS) CFO sells 2,127 shares after exercising options - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 2 July By Investing.com - Investing.com Nigeria
Levy Raphi to sell 20,000 Alpha Tau shares (DRTS) via Form 144 - Stock Titan
Alpha Tau Medical Ltd. Warrant 2022-07.03.27 on Alpha Tau Med Rg-A Financial Disclosures & SEC Filings - TradingView
CFO’s Bold Stock Move Sends Fresh Signals at Alpha Tau Medical - TipRanks
Major Insider Move at Alpha Tau Medical Ltd Shakes Up Investor Watchlists - TipRanks
Insider Sell: Raphi Levy Sells 20,000 Shares of Alpha Tau Medica - GuruFocus
Alpha Tau Medical (DRTS) CFO sells 20,000 shares, retains 90,180 - Stock Titan
Alpha Tau Medical stock hits 52-week high at $11.64 By Investing.com - Investing.com South Africa
Alpha Tau Medical stock hits 52-week high at $11.64 - Investing.com UK
Form 144 Alpha Tau Medical Ltd. For: 30 June By Investing.com - Investing.com South Africa
Insider sells 37,500 shares at Alpha Tau Medical (NASDAQ: DRTS) - Stock Titan
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Why Alpha Tau Medical (DRTS) Is Up 11.2% After First Alpha DaRT Brain-Tumor Procedure News - Sahm
Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform - Yahoo Finance
Form 144 Alpha Tau Medical Ltd. For: 26 June By Investing.com - Investing.com South Africa
Alpha Tau Medical (DRTS) CFO sells 20,000 Ordinary Shares - Stock Titan
Raphi Levy sale: 17,500 shares disclosed for Alpha Tau Medical (DRTS) - Stock Titan
Alpha Tau Medical (DRTS) Looks Fully Priced After Its Glioblastoma Treatment Milestone - simplywall.st
CFO’s Surprise Stock Move at Alpha Tau Medical Shakes Up Investor Buzz - TipRanks
Alpha Tau Medical (NASDAQ: DRTS) shareholders back board, pay and auditor at AGM - Stock Titan
Alpha Tau Medical Ltd Actuals & Estimates (NASDAQ:DRTS) - TradingView
Insider Sell Alert: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - PR Newswire
Alpha Tau Medical (DRTS) CFO reports open-market sale of 17,500 shares - Stock Titan
Alpha Tau Medical Ltd (DRTSW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Alpha Tau Medical Ltd (DRTSW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 6K Alpha Tau Medical Ltd For: 23 June By Investing.com - Investing.com India
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel - TipRanks
Alpha Tau Medical (Nasdaq: DRTS) treats first recurrent glioblastoma patient outside U.S. - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 23 June By Investing.com - Investing.com Australia
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):